Additionally, the study validated the amelioration of tau hyperphosphorylation by xanthohumol on HEK293/Tau cells, another cell line with tau hyperphosphorylation.[282] The data suggest the capacity of xanthohumol against fibrillary pathology and cytoprotection in AD. The gene discussed is MAPT; the disease is Alzheimer disease.